LONDON - ENGLAND - SEPTEMBER 17: Dr Felicity Hartnell, who is a clinical research fellow at Oxford University, holds the vile of the ebola vaccine called Chimp Adenovirus type 3 (ChAd3) before the first healthy UK volunteer receives an ebola vaccine at the Oxford Vaccine Group Centre for Clinical Vaccinology and Tropical Medicine (CCVTM) on September 17, 2014 in Oxford, England. (Photo by Steve Parsons-WPA Pool/Getty Images)
The death of Ebola?
01:32 - Source: CNN
CNN  — 

Authorities will begin distributing an experimental Ebola vaccine in Mbandaka, a major city in the Democratic Republic of Congo, on Monday to try to stop the spread of the deadly virus.

Healthcare workers in Mbandaka, the capital of Equateur Province and home to 1.2 million people, will be the first to receive the vaccine, followed by contacts of confirmed Ebola cases, World Health Organization (WHO) spokesman Tarik Jašarević said.

The vaccination drive is expected to reach rural Bikoro, the epicenter of the outbreak, by Thursday.

The confirmation of the first case in Mbandaka last week has raised concerns that the virus could spread faster than expected. So far, 26 people have died in the outbreak, according to the WHO.

The vaccine, called rVSV-ZEBOV, will likely be distributed to some 8,000 to 10,000 people in its first phase, Peter Salama, deputy director-general of emergency preparedness and response at the WHO, said Friday.

It will be given to people who have had contact with people infected with Ebola and contacts of those contacts, Salama said.

“We’re much better placed to deal with this outbreak than we were in 2014,” said WHO Director General Tedros Adhanom Ghebreyesus.

Ebola is a highly infectious virus which causes a sudden onset of symptoms including fever, fatigue and muscle pain within two to 21 days after infection. Patients suffer vomiting, rash and diarrhea, impaired kidney and liver function – and in some cases internal and external bleeding.

An outbreak in 2014 in West Africa killed more than 11,000 people in months.

Experimental vaccine

The rVSV-ZEBOV vaccine was previously given to people in contact with patients who had confirmed cases of Ebola in Guinea in 2015 and 2016, and proved quite effective.

But this will be the first time the vaccine is being employed to control the spread of Ebola, according to Dr. Anthony Fauci, the director of the National Institute of Allergy and Infectious Diseases in the United States.

The WHO has already deployed more than 5,000 doses of the experimental vaccine in Kinshasa, the country’s capital, with thousands more expected to arrive.

This is the messy truth about Ebola still from graphic package
This is the messy truth about Ebola
02:18 - Source: CNN

46 cases reported

Of the 46 cases of hemorrhagic fever identified by authorities, 21 confirmed have been confirmed as Ebola, while 21 are probable and 4 are suspected, according to Jašarević.

The WHO said Friday that there has been one confirmed case in Mbandaka. DRC Health Minister Dr. Oly Ilunga Kalenga said the discovery of the case in Mbandaka was particularly worrisome, as the Ebola virus is highly contagious once victims start showing symptoms.

Nine neighboring countries, including Republic of the Congo and Central African Republic, have been advised that they are at high risk of spread and have been supported with equipment and personnel.

The World Health Organization held an emergency meeting Friday and declared that the situation is not yet a so-called Public Health Emergency of International Concern.

WHO Director-General Tedros Adhanom Ghebreyesus is expected to address the annual world Health Assembly on Monday and is expected to discuss the outbreak.

The US Agency for International Development has already given $1 million to fight the Ebola outbreak.

CNN’s Euan McKirdy, Jacqueline Howard, David McKenzie and Sara Mazloumsaki contributed to this article.